SEBASTIANI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 31.143
EU - Europa 26.188
AS - Asia 15.483
SA - Sud America 2.143
AF - Africa 389
OC - Oceania 123
Continente sconosciuto - Info sul continente non disponibili 26
Totale 75.495
Nazione #
US - Stati Uniti d'America 30.418
IT - Italia 14.927
SG - Singapore 4.575
GB - Regno Unito 4.239
CN - Cina 4.075
HK - Hong Kong 1.766
BR - Brasile 1.596
VN - Vietnam 1.491
SE - Svezia 1.334
DE - Germania 934
FR - Francia 910
FI - Finlandia 835
BD - Bangladesh 785
UA - Ucraina 659
RU - Federazione Russa 580
KR - Corea 538
NL - Olanda 533
TR - Turchia 524
IN - India 367
CA - Canada 337
JP - Giappone 295
ID - Indonesia 286
MX - Messico 252
BG - Bulgaria 248
IE - Irlanda 206
AR - Argentina 190
PL - Polonia 133
ZA - Sudafrica 130
AU - Australia 112
IQ - Iraq 112
PK - Pakistan 95
CH - Svizzera 89
EC - Ecuador 83
ES - Italia 81
AE - Emirati Arabi Uniti 76
CL - Cile 72
LT - Lituania 72
MY - Malesia 72
TN - Tunisia 66
CO - Colombia 64
BE - Belgio 63
RO - Romania 58
SA - Arabia Saudita 57
AT - Austria 56
EG - Egitto 48
VE - Venezuela 46
PH - Filippine 44
IR - Iran 41
MA - Marocco 38
TH - Thailandia 35
BZ - Belize 32
NP - Nepal 32
JO - Giordania 31
UZ - Uzbekistan 31
PE - Perù 30
PT - Portogallo 30
TW - Taiwan 27
KE - Kenya 26
DZ - Algeria 24
PY - Paraguay 24
CZ - Repubblica Ceca 22
DK - Danimarca 22
EU - Europa 21
AZ - Azerbaigian 20
GR - Grecia 20
HU - Ungheria 20
BO - Bolivia 19
HN - Honduras 16
IL - Israele 16
UY - Uruguay 16
AL - Albania 15
LV - Lettonia 15
OM - Oman 15
LB - Libano 14
TT - Trinidad e Tobago 14
DO - Repubblica Dominicana 13
RS - Serbia 13
JM - Giamaica 12
BY - Bielorussia 11
HR - Croazia 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
PA - Panama 10
KG - Kirghizistan 9
LU - Lussemburgo 9
CY - Cipro 8
ET - Etiopia 8
CR - Costa Rica 7
KW - Kuwait 7
MD - Moldavia 7
NI - Nicaragua 7
QA - Qatar 7
SN - Senegal 7
PR - Porto Rico 6
SK - Slovacchia (Repubblica Slovacca) 6
GT - Guatemala 5
KZ - Kazakistan 5
BS - Bahamas 4
CI - Costa d'Avorio 4
KH - Cambogia 4
Totale 75.397
Città #
Singapore 3.134
Santa Clara 3.019
Southend 2.843
Ashburn 2.613
Fairfield 2.496
Hong Kong 1.720
Chandler 1.403
Woodbridge 1.392
Hefei 1.383
Milan 1.180
Houston 1.158
San Jose 1.096
Rome 1.038
Jacksonville 946
Seattle 893
Wilmington 893
Chicago 883
Cambridge 784
Ann Arbor 783
Los Angeles 773
London 735
Nyköping 687
Council Bluffs 675
Dearborn 669
Helsinki 633
Beijing 630
The Dalles 494
Seoul 476
Ho Chi Minh City 437
New York 401
Salt Lake City 400
Modena 379
Hanoi 377
Bologna 271
San Diego 263
Florence 261
Naples 257
Izmir 244
Dallas 239
Princeton 234
Sofia 234
Lauterbourg 211
Turin 207
Buffalo 206
Jakarta 198
Palermo 192
Redwood City 190
Moscow 186
Eugene 182
Bari 181
Tampa 174
Shanghai 163
Elk Grove Village 162
Tokyo 160
Dublin 153
São Paulo 153
Genoa 146
Des Moines 139
Frankfurt am Main 136
Catania 126
Verona 123
Bremen 112
Cagliari 104
Columbus 103
Boardman 101
Padova 99
Orem 93
Falls Church 91
Toronto 90
Sterling 87
Da Nang 84
Mexico City 79
Brescia 76
Munich 76
Atlanta 74
Guangzhou 73
Lancaster 68
Manchester 67
Parma 67
Brooklyn 65
Phoenix 65
Kent 63
Montreal 59
Warsaw 57
Haiphong 56
Miami 56
Chennai 55
Redondo Beach 55
Detroit 54
Monza 53
Denver 52
Dulles 49
Johannesburg 49
Bergamo 47
Perth 47
Perugia 47
Salerno 47
Amsterdam 46
Messina 45
Mumbai 45
Totale 45.470
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 6.953
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.855
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.362
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.306
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 957
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 781
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 697
Semeiotica dell'articolazione temporo-mandibolare 559
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 481
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 455
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 440
B-cells and mixed cryoglobulinemia 440
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 414
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 413
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 405
Validation of the classification criteria for cryoglobulinaemic vasculitis 393
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 391
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 388
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 388
Thymus alterations and systemic sclerosis 383
Heart involvement and systemic sclerosis 377
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 373
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 365
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 360
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 358
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 356
Current treatment of hepatitis C-associated rheumatic diseases. 355
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 354
Cardiac Involvement in Systemic Vasculitis 351
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 348
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 348
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 346
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 345
Aortic pulse wave velocity measurement in systemic sclerosis patients. 342
Elevated Troponin Serum Levels in Adult Onset Still's Disease 341
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 339
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 337
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 328
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 325
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 324
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 323
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 322
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 322
L-Arginine in pregnant scleroderma patients 322
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 318
Acute exacerbation of interstitial lung disease associated with rheumatic disease 317
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 316
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 315
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 315
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 311
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 309
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 308
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 307
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 307
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 304
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 302
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 301
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 300
HCV and cryoglobulinemic vasculitis. 296
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 294
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 294
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 289
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 288
Cardiovascular risk and prostanoids in systemic sclerosis 285
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 285
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 284
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 283
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 282
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 282
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 281
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 279
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 279
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 279
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 278
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? 276
HCV associated cryoglobulinemic vasculitis 275
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 275
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 274
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 274
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 274
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 273
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 273
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 273
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 271
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 270
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 270
New targeted molecular therapies for dedifferentiated thyroid cancer 267
Systemic sclerosis following human cytomegalovirus infection 261
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 260
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 260
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 258
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 257
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 257
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 257
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 256
Treatment of HCV-related mixed cryoglobulinemia 255
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 255
HCV-related rheumatic manifestations and therapeutic strategies 254
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 252
Totale 45.578
Categoria #
all - tutte 275.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 275.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021471 0 0 0 0 0 0 0 0 0 0 0 471
2021/20225.162 278 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/202513.591 705 370 449 972 2.413 1.779 920 700 1.426 881 1.393 1.583
2025/202624.038 1.347 916 1.897 3.068 4.300 1.706 2.732 1.032 2.081 1.772 1.722 1.465
Totale 76.151